Evaluation of ipsilateral increased vascularity in differentiating benign and malignant breast lesions

被引:0
|
作者
Wang, Haili [1 ]
Xu, Yaping [3 ]
Yao, Zhigang [2 ]
Zhan, Haiyu [1 ]
Liu, Qingwei [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Radiol, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Hosp, Dept Pathol, Jinan, Shandong, Peoples R China
[3] Shandong Prov Third Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China
关键词
Ipsilateral increased vascularity; breast cancer; benign and malignant lesion; dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI); differential diagnosis; ENHANCED MR MAMMOGRAPHY; GADOBENATE DIMEGLUMINE; GADOPENTETATE DIMEGLUMINE; CANCER; ANGIOGRAPHY; DIAGNOSIS; ANGIOGENESIS; ULTRASOUND; GADOBUTROL; IMAGES;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study aimed to evaluate one-sided increased vascularity in contrast-enhanced breast MRIs in differential diagnosis of benign and malignant breast lesions. A total of 36 patients with breast lesions were included. They were examined by MRIs and tissue samples were subjected to pathological diagnosis. Maximum intensity projections (MIPs) were scored, according to a previously published method. Differences in vascularity between benign and malignant breast lesions were analyzed and compared. According to MRIs for these 36 patients, there were 36 lesions (14 benign and 22 malignant lesions based on histological detection). The mean vessel number in breasts with malignant lesions was 4.0 +/- 1.5, significantly higher than in breasts with benign lesions (2.2 +/- 1.6 vessels). Mean MIP scores for breasts with malignant and benign lesions were 2.4 +/- 0.5 and 1.6 +/- 0.8, respectively. Moreover, overall sensitivity and specificity percentages of one-sided increased vascularity associated with ipsilateral malignancy were 100% and 36%, respectively. Based on morphologic and kinetic data analysis, sensitivity and specificity of breast MRIs were 100% and 64%, respectively. However, according to morphologic, kinetic, and vascular map analyses, sensitivity and specificity of breast MRIs were 100% and 57%, respectively, without increased specificity. Vessel numbers and mean MIP scores differed between breasts with benign and malignant lesions. Therefore, ipsilateral increased vascularity might be a reliable sign for differentiating benign and malignant breast lesions.
引用
收藏
页码:4100 / 4107
页数:8
相关论文
共 50 条
  • [41] Editorial for "Differentiating benign and malignant breast lesions in diffusion kurtosis MRI: Does the averaging procedure matter?"
    Karan, Belgin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 56 (05) : 1353 - 1354
  • [42] Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging
    Kvistad, KA
    Lundgren, S
    Fjosne, HE
    Smenes, E
    Smethurst, HB
    Haraldseth, O
    ACTA RADIOLOGICA, 1999, 40 (01) : 45 - 51
  • [43] SEMI-QUANTITATIVE AND QUALITATIVE ASSESSMENT OF BREAST ULTRASOUND ELASTOGRAPHY IN DIFFERENTIATING BETWEEN MALIGNANT AND BENIGN LESIONS
    Alhabshi, Sharifah Majedah Idrus
    Rahmat, Kartini
    Halim, Nurazidawati Abdul
    Aziz, Suraya
    Radhika, Sridharan
    Gan, Gek Choo
    Vijayananthan, Anushya
    Westerhout, Caroline Judy
    Mohd-Shah, Mohammad Nazri
    Jaszle, Saladina
    Latar, Nani Harlina Mohd
    Muhammad, Rohaizak
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2013, 39 (04): : 568 - 578
  • [44] Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China
    Fan, Wei Xiong
    Chen, Xiao Feng
    Cheng, Feng Yan
    Cheng, Ya Bao
    Xu, Tai
    Zhu, Wen Biao
    Zhu, Xiao Lei
    Li, Gui Jin
    Li, Shuai
    MEDICINE, 2018, 97 (04)
  • [45] PRELIMINARY APPLICATION OF CONTRAST-ENHANCED CONE-BEAM BREAST CT IN DIFFERENTIATING BENIGN AND MALIGNANT BREAST LESIONS
    Ye, Zhaoxiang
    Han, Peng
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 119 - 119
  • [46] DNA fingerprinting of benign and malignant breast lesions
    Sibbering, M
    ORourke, S
    Stanley, J
    Gilmour, A
    Reid, A
    Parkin, D
    Ellis, I
    Elston, C
    Blamey, R
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (06): : 574 - 577
  • [47] BENIGN AND MALIGNANT LESIONS OF THE BREAST IN POSTMENOPAUSAL WOMEN
    DAO, TL
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1964, 7 (02): : 603 - 620
  • [48] HuR expression in breast benign and malignant lesions
    Sampani, A.
    Tsourouflis, G.
    Vgenopoulou, S.
    Stolakis, V
    Kouraklis, G.
    Klijanienko, J.
    Theocharis, S.
    VIRCHOWS ARCHIV, 2009, 455 : 100 - 100
  • [49] Expression of hyaluronan in benign and malignant breast lesions
    Auvinen, PK
    Parkkinen, JJ
    Johansson, RT
    Agren, UM
    Tammi, RH
    Eskelinen, MJ
    Kosma, VM
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (05) : 477 - 481
  • [50] Benign and malignant spindle cell lesions of the breast
    Brogi, E
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2004, 21 (01) : 57 - 64